Jennifer Burkham, MD
Rheumatology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 25
- 6 carriers
- Offices
- 3
Offices
3 locations · County of Santa Clara · County of San Mateo
Looking this up.
Hospitals listed: San Mateo Medical Center · Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
25 plans · 6 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Burkham’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
25 of 25 plans
| Aetna Medicare Eagle (PPO) | Aetna Medicare | Listed | Sep 8, 2026 |
| Aetna Medicare Enhanced (PPO) | Aetna Medicare | Listed | Sep 8, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A85894 · Current
Licensed to practise in California · since 2004 · expires 2027-11-30 · University of Southern California Keck School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- San Mateo Medical CenterSan Mateo, CAAcute Care Hospital · Government - Local · Has an emergency departmentPart of San Mateo County HealthPatients rate it 3 of 5 · 68% would definitely recommend itNo overall ratingNo measure marked better or worse than the national rate
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for San Mateo Medical Center
Behind the star rating — Deaths: 0 better, 2 the same, 0 worse of 2 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 3 the same, 0 worse of 3 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.34 (0.25 to 2.43) · 45 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.97 (0.48 to 1.47) | No different | Jul 2022 – Jun 2024 |
| Death rate for pneumonia patientsComplications and deaths | 13.9 · 25 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 258 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.44) · 379 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 381 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.44 (0.82 to 6.05) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.64 (0.92 to 4.37) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.53 (0 to 1.76) · 296 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.661 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.8 · 47 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -2.3 · 25 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 76 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14 (10.4 to 18.9) · 167 cases | No different | Jan 2022 – Dec 2024 |
What patients said (208 patients answered, 15% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 68% |
| Staff "always" explained possible side effects | 51% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$15,952
Medicare paid this office $15,952 for 125 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 102 | $11,647 | $70 |
| Aspiration and/or injection of fluid from large joint | 17 | $880 | $44 |
Who their Medicare patients are
125 Original Medicare patients in 2024. Average age 71 · Under 65 18% · 85 and older 11% · Women 77% · Also on Medicaid 83% · Health risk score 1.67. Above the middle of the specialty; the typical rheumatology clinician is at 1.38.
Conditions among them: High blood pressure 75% · Diabetes 30% · Coronary heart disease 23% · Depression 22% · Chronic kidney disease 20% · Heart failure 15% · Atrial fibrillation 14% · Cancer 10% · COPD 9%.
The office billed $168,733, Medicare allowed $24,156 and paid $15,952; for 234 services of 17 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 125 | 234 | 71 | 1.67 | $168,733 | $15,952 |
| 2023 | 135 | 269 | 71 | 1.67 | $192,678 | $18,396 |
| 2022 | 127 | 250 | 71 | 1.49 | $162,006 | $16,161 |
| 2021 | 152 | 296 | 70 | 1.52 | $171,856 | $18,052 |
| 2020 | 139 | 274 | 69 | 1.83 | $153,681 | $13,756 |
| 2019 | 162 | 338 | 69 | 1.61 | $204,275 | $19,646 |
| 2018 | 155 | 388 | 67 | 1.59 | $215,497 | $20,558 |
| 2017 | 142 | 375 | 67 | 1.33 | $182,258 | $19,338 |
| 2016 | 160 | 434 | 67 | 1.57 | $155,514 | $19,470 |
| 2015 | 165 | 530 | 67 | 1.34 | $150,569 | $23,397 |
| 2014 | 179 | 726 | 67 | 1.39 | $179,547 | $32,874 |
| 2013 | 180 | 622 | 66 | 1.36 | $146,809 | $26,684 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Return visit (30+ min) | 114 | $13,741 | $72 |
| Aspiration and/or injection of fluid from large joint | 14 | $994 | $43 |
| Short return visit (20+ min) | 12 | $760 | $51 |
2022: 3 services
| Return visit (30+ min) | 96 | $10,844 | $73 |
| Short return visit (20+ min) | 27 | $1,890 | $56 |
| Aspiration and/or injection of fluid from large joint | 17 | $1,160 | $37 |
2021: 3 services
| Return visit (30+ min) | 95 | $9,341 | $83 |
| Short return visit (20+ min) | 78 | $3,879 | $42 |
| Aspiration and/or injection of fluid from large joint | 28 | $1,306 | $37 |
2020: 5 services
| Return visit (30+ min) | 99 | $7,504 | $55 |
| Telephone medical discussion with physician, 11-20 minutes | 27 | $1,045 | $37 |
| Aspiration and/or injection of fluid from large joint | 19 | $1,019 | $44 |
| Short return visit (20+ min) | 18 | $768 | $43 |
| Telephone medical discussion with physician, 5-10 minutes | 20 | $308 | $15 |
2019: 4 services
| Return visit (30+ min) | 116 | $12,191 | $59 |
| New patient visit (45+ min) | 21 | $2,144 | $102 |
| Aspiration and/or injection of fluid from large joint | 34 | $1,699 | $40 |
| Short return visit (20+ min) | 14 | $653 | $47 |
2018: 6 services
| Return visit (30+ min) | 98 | $11,895 | $58 |
| Aspiration and/or injection of fluid from large joint | 36 | $2,255 | $43 |
| New patient visit (45+ min) | 19 | $1,701 | $90 |
| New patient visit (30+ min) | 21 | $1,318 | $63 |
| Short return visit (20+ min) | 23 | $1,057 | $35 |
| Injection into tendon or ligament | 16 | $637 | $24 |
2017: 3 services
| Return visit (30+ min) | 99 | $11,534 | $59 |
| Aspiration and/or injection of fluid from large joint | 45 | $3,276 | $44 |
| Short return visit (20+ min) | 41 | $2,215 | $40 |
2016: 4 services
| Return visit (30+ min) | 107 | $11,833 | $56 |
| Short return visit (20+ min) | 54 | $2,498 | $39 |
| Aspiration and/or injection of fluid from large joint | 37 | $2,382 | $34 |
| Injection into tendon or ligament | 14 | $639 | $28 |
2015: 3 services
| Return visit (30+ min) | 115 | $13,753 | $54 |
| Short return visit (20+ min) | 53 | $3,441 | $38 |
| Aspiration and/or injection of fluid from large joint | 48 | $3,358 | $31 |
2014: 10 services
| Return visit (30+ min) | 131 | $18,843 | $59 |
| Aspiration and/or injection of fluid from large joint | 53 | $4,544 | $32 |
| Short return visit (20+ min) | 56 | $4,003 | $40 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 11 | $982 | $89 |
| Administration of influenza virus vaccine | 28 | $871 | $31 |
| Injection into tendon or ligament | 12 | $674 | $35 |
| Administration of pneumococcal vaccine | 18 | $560 | $31 |
| Pneumococcal vaccine, 23-valent | 18 | $459 | $25 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 15 | $266 | $18 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 14 | $231 | $17 |
2013: 3 services
| Return visit (30+ min) | 95 | $14,545 | $58 |
| Short return visit (20+ min) | 82 | $4,946 | $36 |
| Aspiration and/or injection of fluid from large joint | 61 | $4,421 | $26 |
Medicaid work
$7,285 in 2024
Medicaid paid $7,285 for 2,101 billed services this clinician did in 2024, up to 78 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 556 | $7,285 |
| Pain severity quantified; pain present (COA) (ONC) | 27 | $0 |
| Medication list documented in medical record (COA) | 435 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 39 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 372 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 142 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 424 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 106 | $0 |
| 2024 | 2,101 | 8 | 78 | $7,285 |
| 2023 | 956 | 11 | 88 | $4,984 |
| 2022 | 702 | 10 | 60 | $5,290 |
| 2021 | 1,573 | 12 | 52 | $10,287 |
| 2020 | 365 | 3 | 58 | $3,526 |
| 2019 | 501 | 6 | 55 | $3,416 |
| 2018 | 516 | 6 | 44 | $2,773 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 627 | $4,515 |
| Measurement of C-reactive protein | 25 | $141 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 14 | $106 |
| HEPATIC FUNCTION PANEL | 13 | $102 |
| Sedimentation rate, erythrocyte; non-automated | 25 | $96 |
| Creatinine; blood | 13 | $25 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 38 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 65 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 31 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 92 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 13 | $0 |
2022
| Return visit (30+ min) | 405 | $3,465 |
| HEPATIC FUNCTION PANEL | 44 | $393 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 44 | $379 |
| Measurement of C-reactive protein | 45 | $258 |
| Complement; antigen, each component | 19 | $231 |
| Thyroid stimulating hormone (TSH) | 12 | $209 |
| Creatinine; blood | 70 | $134 |
| Creatinine; other source | 16 | $85 |
| Total protein level, urine | 31 | $74 |
| Sedimentation rate, erythrocyte; non-automated | 16 | $60 |
2021
| Return visit (30+ min) | 375 | $2,917 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 171 | $1,495 |
| HEPATIC FUNCTION PANEL | 156 | $1,409 |
| Measurement of C-reactive protein | 160 | $935 |
| Complement; antigen, each component | 53 | $911 |
| Sedimentation rate, erythrocyte; non-automated | 162 | $644 |
| Thyroid stimulating hormone (TSH) | 31 | $599 |
| Creatinine; blood | 196 | $396 |
| Creatinine; other source | 56 | $319 |
| Total protein level, urine | 123 | $300 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy | 53 | $186 |
| Short return visit (20+ min) | 37 | $175 |
2020
| Return visit (30+ min) | 325 | $3,395 |
| Creatinine; blood | 28 | $71 |
| New patient visit (45+ min) | 12 | $60 |
2019
| Return visit (30+ min) | 431 | $3,030 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 14 | $123 |
| HEPATIC FUNCTION PANEL | 14 | $122 |
| Measurement of C-reactive protein | 14 | $82 |
| Sedimentation rate, erythrocyte; non-automated | 14 | $56 |
| Creatinine; blood | 14 | $2 |
2018
| Return visit (30+ min) | 372 | $1,978 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 29 | $256 |
| HEPATIC FUNCTION PANEL | 29 | $254 |
| Measurement of C-reactive protein | 29 | $170 |
| Sedimentation rate, erythrocyte; non-automated | 28 | $113 |
| Creatinine; blood | 29 | $4 |
Drugs they prescribed that Part D paid
$2,729,508
Pharmacies billed $2,729,508 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 8% of their Part D prescriptions (145 of 1,765) in 2024. Above the middle of the specialty; the typical rheumatology clinician is at 3%.
1,241 generic and 524 brand-name prescriptions · $2,729,508 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Humira | 171 | $1,182,035 | $6,912 |
| Xeljanz | 103 | $562,537 | $5,462 |
| Orencia Clickject | 52 | $264,623 | $5,089 |
| Enbrel | 24 | $169,282 | $7,053 |
| Enbrel Sureclick | 19 | $129,110 | $6,795 |
See all 35 drugs
| Humira | 171 | $1,182,035 | $6,912 |
| Xeljanz | 103 | $562,537 | $5,462 |
| Orencia Clickject | 52 | $264,623 | $5,089 |
| Enbrel | 24 | $169,282 | $7,053 |
| Enbrel Sureclick | 19 | $129,110 | $6,795 |
| Rinvoq | 14 | $113,774 | $8,127 |
| Orencia | 17 | $85,942 | $5,055 |
| Actemra Actpen | 14 | $31,357 | $2,240 |
| Rasuvo | 29 | $14,160 | $488 |
| Hydroxychloroquine Sulfate | 181 | $5,375 | $30 |
| Leflunomide | 56 | $4,631 | $83 |
| Methotrexate | 98 | $2,511 | $26 |
| Mycophenolate Mofetil | 21 | $2,067 | $98 |
| Lidocaine | 26 | $1,916 | $74 |
| Diclofenac | 83 | $1,736 | $21 |
| Febuxostat | 19 | $1,732 | $91 |
| Acetaminophen-Codeine | 53 | $1,028 | $19 |
| Gabapentin | 114 | $995 | $9 |
| Pilocarpine | 14 | $980 | $70 |
| Sulfasalazine | 36 | $964 | $27 |
| Prednisone | 103 | $833 | $8 |
| Hydrocodone-Acetaminophen | 47 | $750 | $16 |
| Colchicine | 17 | $716 | $42 |
| Ibuprofen | 35 | $660 | $19 |
| Azathioprine | 25 | $634 | $25 |
| Nystatin | 30 | $629 | $21 |
| Allopurinol | 38 | $339 | $9 |
| Omeprazole | 20 | $317 | $16 |
| Folic Acid | 11 | $235 | $21 |
| Alendronate | 18 | $126 | $7 |
| Valacyclovir | 11 | $122 | $11 |
| Triamcinolone Acetonide | 12 | $100 | $8 |
| Fluticasone Propionate | 12 | $73 | $6 |
| Tramadol | 29 | $63 | $2 |
| Famotidine | 12 | $37 | $3 |
Year by year
| 2024 | 1,765 | 187 | 8% (145) | 30% | $2,729,508 |
| 2023 | 1,668 | 186 | 8% (137) | 31% | $3,024,468 |
| 2022 | 1,507 | 175 | 7% (111) | 31% | $2,326,345 |
| 2021 | 1,503 | 172 | 9% (140) | 29% | $2,276,704 |
| 2020 | 1,616 | 150 | 10% (164) | None | $2,111,866 |
| 2019 | 1,597 | 179 | 13% (200) | 38% | $2,303,704 |
| 2018 | 1,207 | 151 | 15% (178) | None | $1,435,573 |
| 2017 | 1,271 | 147 | 15% (193) | None | $1,079,480 |
| 2016 | 1,533 | 174 | 17% (260) | None | $855,198 |
| 2015 | 1,911 | 201 | 18% (351) | None | $810,598 |
| 2014 | 1,952 | 203 | 18% (357) | None | $595,327 |
| 2013 | 2,025 | 199 | 21% (416) | None | $564,110 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 36 drugs
| Humira | 162 | $1,205,715 | $7,443 |
| Xeljanz | 93 | $565,578 | $6,081 |
| Orencia Clickject | 48 | $271,889 | $5,664 |
| Enbrel | 36 | $238,873 | $6,635 |
| Enbrel Sureclick | 30 | $210,704 | $7,023 |
| Rinvoq | 18 | $169,256 | $9,403 |
| Cosentyx Sensoready (2 Pens) | 13 | $100,727 | $7,748 |
| Humira | 11 | $78,129 | $7,103 |
| Simponi | 11 | $61,994 | $5,636 |
| Kevzara | 12 | $33,821 | $2,818 |
| Rasuvo | 34 | $20,337 | $598 |
| Hydroxychloroquine Sulfate | 188 | $10,098 | $54 |
| Methotrexate | 99 | $4,558 | $46 |
| Lidocaine | 30 | $3,883 | $129 |
| Febuxostat | 12 | $3,248 | $271 |
| Leflunomide | 43 | $2,713 | $63 |
| Diclofenac | 100 | $2,190 | $22 |
| Mycophenolate Mofetil | 21 | $2,099 | $100 |
| Nystatin | 46 | $1,788 | $39 |
| Acetaminophen-Codeine | 67 | $1,671 | $25 |
| Sulfasalazine | 35 | $1,650 | $47 |
| Gabapentin | 74 | $1,109 | $15 |
| Alendronate | 46 | $960 | $21 |
| Prednisone | 60 | $896 | $15 |
| Colchicine | 11 | $812 | $74 |
| Hydrocodone-Acetaminophen | 35 | $755 | $22 |
| Valacyclovir | 12 | $643 | $54 |
| Ibuprofen | 30 | $621 | $21 |
| Azathioprine | 16 | $482 | $30 |
| Allopurinol | 25 | $379 | $15 |
| Omeprazole | 18 | $363 | $20 |
| Amlodipine Besylate | 12 | $261 | $22 |
| Tramadol | 24 | $229 | $10 |
| Oxycodone-Acetaminophen | 11 | $116 | $11 |
| Carvedilol | 12 | $37 | $3 |
| Folic Acid | 16 | $31 | $2 |
2022: 31 drugs
| Humira | None | 106 | $652,596 | $6,157 |
| Xeljanz | None | 95 | $501,598 | $5,280 |
| Enbrel Sureclick | None | 46 | $314,496 | $6,837 |
| Enbrel | None | 50 | $276,655 | $5,533 |
| Orencia Clickject | None | 37 | $156,828 | $4,239 |
| Humira | None | 11 | $83,071 | $7,552 |
| Cosentyx Pen (2 Pens) | None | 13 | $81,442 | $6,265 |
| Panzyga | Immune globulin | 12 | $53,599 | $4,467 |
| Kevzara | None | 13 | $35,846 | $2,757 |
| Prolia | None | 12 | $16,802 | $1,400 |
| Rasuvo | None | 22 | $12,223 | $556 |
| Hydroxychloroquine Sulfate | None | 178 | $8,118 | $46 |
| Leflunomide | None | 69 | $8,048 | $117 |
| Methotrexate | None | 94 | $4,918 | $52 |
| Mycophenolate Mofetil | None | 14 | $2,773 | $198 |
| Lidocaine | None | 35 | $2,525 | $72 |
| Diclofenac | None | 57 | $1,533 | $27 |
| Sulfasalazine | None | 26 | $1,446 | $56 |
| Acetaminophen-Codeine | None | 43 | $1,357 | $32 |
| Prednisone | None | 68 | $1,168 | $17 |
| Nystatin | None | 36 | $1,068 | $30 |
| Hydrocodone-Acetaminophen | None | 39 | $893 | $23 |
| Azathioprine | None | 17 | $891 | $52 |
| Gabapentin | None | 69 | $751 | $11 |
| Alendronate | None | 45 | $603 | $13 |
| Omeprazole | None | 18 | $463 | $26 |
| Allopurinol | None | 29 | $448 | $15 |
| Ibuprofen | None | 33 | $425 | $13 |
| Oxycodone-Acetaminophen | None | 11 | $373 | $34 |
| Tramadol | None | 18 | $210 | $12 |
| Folic Acid | None | 19 | $140 | $7 |
2021: 33 drugs
| Humira | 126 | $836,265 | $6,637 |
| Xeljanz | 79 | $416,103 | $5,267 |
| Enbrel | 56 | $314,647 | $5,619 |
| Enbrel Sureclick | 38 | $236,199 | $6,216 |
| Orencia Clickject | 38 | $166,017 | $4,369 |
| Cosentyx Pen (2 Pens) | 13 | $74,838 | $5,757 |
| Simponi | 12 | $59,101 | $4,925 |
| Kevzara | 11 | $27,672 | $2,516 |
| Rasuvo | 16 | $8,365 | $523 |
| Methotrexate | 109 | $7,227 | $66 |
| Hydroxychloroquine Sulfate | 191 | $6,682 | $35 |
| Leflunomide | 52 | $5,259 | $101 |
| Mitigare | 13 | $3,420 | $263 |
| Mycophenolate Mofetil | 20 | $2,866 | $143 |
| Acetaminophen-Codeine | 49 | $2,369 | $48 |
| Pilocarpine | 18 | $1,516 | $84 |
| Sulfasalazine | 28 | $1,310 | $47 |
| Hydrocodone-Acetaminophen | 53 | $1,305 | $25 |
| Diclofenac | 43 | $1,206 | $28 |
| Prednisone | 53 | $995 | $19 |
| Gabapentin | 82 | $926 | $11 |
| Nystatin | 21 | $856 | $41 |
| Azathioprine | 12 | $691 | $58 |
| Allopurinol | 40 | $501 | $13 |
| Alendronate | 54 | $493 | $9 |
| Ibuprofen | 32 | $476 | $15 |
| Minocycline | 12 | $438 | $37 |
| Omeprazole | 19 | $366 | $19 |
| Oxycodone-Acetaminophen | 11 | $341 | $31 |
| Nabumetone | 14 | $314 | $22 |
| Duloxetine | 16 | $312 | $19 |
| Tramadol | 27 | $141 | $5 |
| Folic Acid | 14 | $84 | $6 |
2020: 30 drugs
| Humira | 148 | $842,752 | $5,694 |
| Xeljanz | 77 | $359,052 | $4,663 |
| Enbrel | 46 | $215,057 | $4,675 |
| Enbrel Sureclick | 31 | $171,685 | $5,538 |
| Orencia Clickject | 34 | $140,276 | $4,126 |
| Simponi | 27 | $111,463 | $4,128 |
| Cosentyx Pen (2 Pens) | 12 | $64,669 | $5,389 |
| Orencia | 13 | $63,727 | $4,902 |
| Kevzara | 13 | $31,117 | $2,394 |
| Hydroxychloroquine Sulfate | 248 | $9,203 | $37 |
| Methotrexate | 122 | $7,532 | $62 |
| Rasuvo | 13 | $6,774 | $521 |
| Leflunomide | 56 | $5,053 | $90 |
| Mycophenolate Mofetil | 26 | $3,509 | $135 |
| Pilocarpine | 24 | $2,725 | $114 |
| Hydrocodone-Acetaminophen | 64 | $1,562 | $24 |
| Sulfasalazine | 47 | $1,559 | $33 |
| Prednisone | 60 | $977 | $16 |
| Acetaminophen-Codeine | 50 | $972 | $19 |
| Duloxetine | 24 | $637 | $27 |
| Gabapentin | 74 | $614 | $8 |
| Alendronate | 53 | $607 | $11 |
| Nystatin | 14 | $599 | $43 |
| Allopurinol | 39 | $512 | $13 |
| Minocycline | 12 | $378 | $32 |
| Omeprazole | 25 | $334 | $13 |
| Ibuprofen | 30 | $325 | $11 |
| Oxycodone-Acetaminophen | 11 | $323 | $29 |
| Nabumetone | 13 | $306 | $24 |
| Tramadol | 39 | $205 | $5 |
2019: 32 drugs
| Humira | 156 | $862,021 | $5,526 |
| Xeljanz | 90 | $397,182 | $4,413 |
| Enbrel Sureclick | 60 | $314,208 | $5,237 |
| Enbrel | 37 | $184,979 | $4,999 |
| Orencia Clickject | 37 | $157,658 | $4,261 |
| Humira | 27 | $138,610 | $5,134 |
| Cosentyx Pen (2 Pens) | 13 | $64,915 | $4,993 |
| Kevzara | 12 | $34,656 | $2,888 |
| Hydroxychloroquine Sulfate | 151 | $18,121 | $120 |
| Leflunomide | 54 | $12,044 | $223 |
| Rasuvo | 18 | $9,302 | $517 |
| Colcrys | 13 | $6,185 | $476 |
| Methotrexate | 122 | $5,823 | $48 |
| Hydrocodone-Acetaminophen | 99 | $2,454 | $25 |
| Sulfasalazine | 50 | $2,094 | $42 |
| Prednisone | 97 | $1,888 | $19 |
| Mycophenolate Mofetil | 17 | $1,769 | $104 |
| Pilocarpine | 15 | $1,703 | $114 |
| Gabapentin | 68 | $876 | $13 |
| Allopurinol | 35 | $822 | $23 |
| Acetaminophen-Codeine | 40 | $691 | $17 |
| Oxycodone-Acetaminophen | 14 | $550 | $39 |
| Nabumetone | 28 | $514 | $18 |
| Nystatin | 11 | $514 | $47 |
| Alendronate | 33 | $460 | $14 |
| Omeprazole | 29 | $408 | $14 |
| Ibuprofen | 25 | $310 | $12 |
| Tramadol | 38 | $226 | $6 |
| Baclofen | 12 | $171 | $14 |
| Naproxen | 11 | $163 | $15 |
| Fluoxetine | 11 | $63 | $6 |
| Insulin | 11 | $13 | $1 |
2018: 30 drugs
| Humira | 128 | $613,905 | $4,796 |
| Xeljanz | 76 | $344,047 | $4,527 |
| Enbrel Sureclick | 39 | $187,619 | $4,811 |
| Enbrel | 15 | $71,116 | $4,741 |
| Orencia Clickject | 14 | $58,616 | $4,187 |
| Humira | 11 | $51,833 | $4,712 |
| Hydroxychloroquine Sulfate | 110 | $15,357 | $140 |
| Leflunomide | 43 | $9,584 | $223 |
| Uloric | 11 | $9,567 | $870 |
| Methotrexate | 99 | $6,506 | $66 |
| Rasuvo | 12 | $5,968 | $497 |
| Hydrocodone-Acetaminophen | 95 | $2,885 | $30 |
| Sulfasalazine | 54 | $1,748 | $32 |
| Prednisone | 74 | $1,586 | $21 |
| Pilocarpine | 14 | $1,546 | $110 |
| Acetaminophen-Codeine | 48 | $969 | $20 |
| Mycophenolate Mofetil | 11 | $918 | $83 |
| Azathioprine | 14 | $738 | $53 |
| Oxycodone-Acetaminophen | 14 | $661 | $47 |
| Nystatin | 13 | $564 | $43 |
| Gabapentin | 41 | $413 | $10 |
| Omeprazole | 31 | $376 | $12 |
| Allopurinol | 17 | $353 | $21 |
| Diclofenac | 13 | $342 | $26 |
| Amitriptyline | 15 | $341 | $23 |
| Nabumetone | 11 | $289 | $26 |
| Alendronate | 25 | $243 | $10 |
| Ibuprofen | 19 | $203 | $11 |
| Tramadol | 17 | $125 | $7 |
| Baclofen | 15 | $120 | $8 |
2017: 26 drugs
| Humira | 110 | $468,893 | $4,263 |
| Xeljanz | 57 | $215,964 | $3,789 |
| Enbrel Sureclick | 37 | $162,265 | $4,386 |
| Humira | 13 | $56,359 | $4,335 |
| Enbrel | 11 | $46,926 | $4,266 |
| Hydroxychloroquine Sulfate | 119 | $23,664 | $199 |
| Leflunomide | 45 | $12,791 | $284 |
| Methotrexate | 110 | $7,585 | $69 |
| Hydrocodone-Acetaminophen | 101 | $2,865 | $28 |
| Sulfasalazine | 62 | $2,343 | $38 |
| Pilocarpine | 15 | $1,628 | $109 |
| Duloxetine | 18 | $1,550 | $86 |
| Prednisone | 64 | $1,291 | $20 |
| Azathioprine | 22 | $1,196 | $54 |
| Acetaminophen-Codeine | 52 | $1,082 | $21 |
| Gabapentin | 56 | $898 | $16 |
| Allopurinol | 23 | $655 | $28 |
| Omeprazole | 35 | $626 | $18 |
| Oxycodone-Acetaminophen | 15 | $463 | $31 |
| Nabumetone | 13 | $417 | $32 |
| Baclofen | 26 | $390 | $15 |
| Ibuprofen | 35 | $290 | $8 |
| Alendronate | 18 | $170 | $9 |
| Naproxen | 13 | $170 | $13 |
| Tramadol | 25 | $159 | $6 |
| Cyclobenzaprine | 15 | $89 | $6 |
2016: 26 drugs
| Humira | 92 | $355,920 | $3,869 |
| Enbrel | 43 | $167,438 | $3,894 |
| Xeljanz | 33 | $111,755 | $3,387 |
| Humira | 23 | $90,319 | $3,927 |
| Hydroxychloroquine Sulfate | 146 | $27,198 | $186 |
| Leflunomide | 37 | $10,135 | $274 |
| Methotrexate | 118 | $7,791 | $66 |
| Hydrocodone-Acetaminophen | 152 | $5,603 | $37 |
| Uloric | 12 | $5,073 | $423 |
| Sulfasalazine | 93 | $3,051 | $33 |
| Lidocaine | 13 | $2,493 | $192 |
| Prednisone | 116 | $1,671 | $14 |
| Acetaminophen-Codeine | 64 | $1,405 | $22 |
| Azathioprine | 31 | $1,285 | $41 |
| Gabapentin | 66 | $1,248 | $19 |
| Omeprazole | 69 | $944 | $14 |
| Voltaren | 11 | $639 | $58 |
| Ibuprofen | 56 | $602 | $11 |
| Baclofen | 39 | $530 | $14 |
| Allopurinol | 19 | $521 | $27 |
| Diclofenac | 15 | $416 | $28 |
| Nabumetone | 12 | $315 | $26 |
| Naproxen | 26 | $275 | $11 |
| Amitriptyline | 17 | $270 | $16 |
| Tramadol | 34 | $238 | $7 |
| Alendronate | 25 | $163 | $7 |
2015: 33 drugs
| Humira | 91 | $302,333 | $3,322 |
| Enbrel | 78 | $249,323 | $3,196 |
| Humira | 23 | $95,091 | $4,134 |
| Xeljanz | 11 | $33,098 | $3,009 |
| Hydroxychloroquine Sulfate | 141 | $27,132 | $192 |
| Nexium | 20 | $11,500 | $575 |
| Methotrexate | 134 | $10,586 | $79 |
| Relistor | 11 | $8,058 | $733 |
| Hydrocodone-Acetaminophen | 209 | $6,899 | $33 |
| Leflunomide | 39 | $4,944 | $127 |
| Uloric | 13 | $3,748 | $288 |
| Sulfasalazine | 118 | $3,423 | $29 |
| Prednisone | 132 | $2,358 | $18 |
| Pilocarpine | 15 | $1,752 | $117 |
| Acetaminophen-Codeine | 81 | $1,577 | $19 |
| Azathioprine | 44 | $1,552 | $35 |
| Gabapentin | 75 | $1,224 | $16 |
| Omeprazole | 81 | $1,178 | $15 |
| Voltaren | 25 | $1,142 | $46 |
| Diclofenac | 24 | $955 | $40 |
| Baclofen | 46 | $748 | $16 |
| Ibuprofen | 59 | $743 | $13 |
| Allopurinol | 21 | $667 | $32 |
| Amitriptyline | 37 | $597 | $16 |
| Naproxen | 38 | $421 | $11 |
| Tramadol | 52 | $404 | $8 |
| Ranitidine | 15 | $278 | $19 |
| Alendronate | 25 | $213 | $9 |
| Meloxicam | 14 | $98 | $7 |
| Amlodipine Besylate | 13 | $85 | $7 |
| Fluoxetine | 12 | $69 | $6 |
| Sulfamethoxazole-Trimethoprim | 13 | $48 | $4 |
| Hydrochlorothiazide | 12 | $48 | $4 |
2014: 35 drugs
| Humira | 83 | $268,483 | $3,235 |
| Enbrel | 61 | $162,363 | $2,662 |
| Orencia | 14 | $34,672 | $2,477 |
| Xeljanz | 13 | $29,973 | $2,306 |
| Nexium | 27 | $11,989 | $444 |
| Methotrexate | 94 | $8,907 | $95 |
| Uloric | 24 | $6,456 | $269 |
| Hydrocodone-Acetaminophen | 248 | $6,380 | $26 |
| Lidoderm | 17 | $4,518 | $266 |
| Hydroxychloroquine Sulfate | 133 | $4,046 | $30 |
| Leflunomide | 52 | $3,692 | $71 |
| Colcrys | 13 | $2,657 | $204 |
| Prednisone | 95 | $2,029 | $21 |
| Sulfasalazine | 67 | $1,984 | $30 |
| Omeprazole | 91 | $1,817 | $20 |
| Gabapentin | 67 | $1,338 | $20 |
| Ibuprofen | 81 | $982 | $12 |
| Acetaminophen-Codeine | 58 | $944 | $16 |
| Azathioprine | 34 | $883 | $26 |
| Baclofen | 46 | $837 | $18 |
| Amitriptyline | 50 | $653 | $13 |
| Diclofenac | 24 | $629 | $26 |
| Naproxen | 45 | $558 | $12 |
| Levetiracetam | 12 | $531 | $44 |
| Tramadol | 48 | $520 | $11 |
| Alendronate | 38 | $457 | $12 |
| Allopurinol | 36 | $380 | $11 |
| Meloxicam | 22 | $271 | $12 |
| Pantoprazole | 17 | $240 | $14 |
| Divalproex | 13 | $232 | $18 |
| Amlodipine Besylate | 29 | $215 | $7 |
| Cyclobenzaprine | 12 | $157 | $13 |
| Ranitidine | 13 | $155 | $12 |
| Fluoxetine | 13 | $135 | $10 |
| Zolpidem | 16 | $114 | $7 |
2013: 33 drugs
| Humira | 78 | $249,547 | $3,199 |
| Enbrel | 77 | $194,764 | $2,529 |
| Nexium | 20 | $12,968 | $648 |
| Methotrexate | 112 | $9,349 | $83 |
| Hydrocodone-Acetaminophen | 277 | $5,767 | $21 |
| Leflunomide | 45 | $4,206 | $93 |
| Hydroxychloroquine Sulfate | 131 | $3,443 | $26 |
| Lidoderm | 11 | $3,045 | $277 |
| Omeprazole | 107 | $2,634 | $25 |
| Colcrys | 11 | $2,400 | $218 |
| Sulfasalazine | 67 | $2,382 | $36 |
| Gabapentin | 54 | $2,077 | $38 |
| Diclofenac | 33 | $1,285 | $39 |
| Acetaminophen-Codeine | 80 | $1,250 | $16 |
| Prednisone | 110 | $1,161 | $11 |
| Tramadol | 54 | $657 | $12 |
| Ibuprofen | 77 | $639 | $8 |
| Nabumetone | 13 | $634 | $49 |
| Alendronate | 43 | $580 | $13 |
| Naproxen | 50 | $561 | $11 |
| Cyclobenzaprine | 27 | $493 | $18 |
| Azathioprine | 19 | $474 | $25 |
| Pantoprazole | 18 | $449 | $25 |
| Baclofen | 49 | $434 | $9 |
| Amitriptyline | 73 | $369 | $5 |
| Amlodipine Besylate | 29 | $261 | $9 |
| Allopurinol | 24 | $242 | $10 |
| Fosinopril | 12 | $196 | $16 |
| Meloxicam | 14 | $185 | $13 |
| Ranitidine | 16 | $130 | $8 |
| Zolpidem | 17 | $128 | $8 |
| Atenolol | 13 | $117 | $9 |
| Hydrochlorothiazide | 22 | $94 | $4 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1174670350
- Licence
- CA A85894California A85894: Current · expires 2027-11-30
- Trained
- University of Southern California Keck School of Medicine, 2002
- Group
- County of Santa Clara · County of San Mateo
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RR0500X (207RR0500X); Internal medicine (207R00000X)
- Mailing address
- 751 S Bascom Ave, Rheumatology Dept, San Jose, CA, 95128
- NPI first listed
- 2007-01-03
- NPI last updated
- 2025-09-11
This is when the NPI record was last certified, not a medical board exam.